Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1965 2
1966 3
1967 8
1968 3
1969 9
1970 10
1971 11
1972 12
1973 14
1974 13
1975 20
1976 7
1977 10
1978 20
1979 10
1980 15
1981 16
1982 18
1983 23
1984 29
1985 27
1986 23
1987 21
1988 27
1989 27
1990 37
1991 30
1992 19
1993 33
1994 35
1995 24
1996 28
1997 32
1998 28
1999 29
2000 39
2001 32
2002 46
2003 36
2004 30
2005 42
2006 44
2007 40
2008 38
2009 28
2010 21
2011 32
2012 55
2013 41
2014 49
2015 67
2016 46
2017 44
2018 57
2019 55
2020 46
2021 39
2022 43
2023 35
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

1,561 results

Results by year

Filters applied: . Clear all
Page 1
Lymphoma: Diagnosis and Treatment.
Lewis WD, Lilly S, Jones KL. Lewis WD, et al. Am Fam Physician. 2020 Jan 1;101(1):34-41. Am Fam Physician. 2020. PMID: 31894937 Free article. Review.
It is traditionally classified broadly as non-Hodgkin or Hodgkin lymphoma. Approximately 82,000 new U.S. patients are diagnosed with lymphoma annually. ...Chemotherapy treatment plans differ between the main subtypes of lymphoma. Non-Hodgkin …
It is traditionally classified broadly as non-Hodgkin or Hodgkin lymphoma. Approximately 82,000 new U.S. patients are d …
Hodgkin lymphoma: A 2020 update on diagnosis, risk-stratification, and management.
Ansell SM. Ansell SM. Am J Hematol. 2020 Aug;95(8):978-989. doi: 10.1002/ajh.25856. Epub 2020 Jun 8. Am J Hematol. 2020. PMID: 32384177 Free article.
DIAGNOSIS: Hodgkin lymphoma is composed of two distinct disease entities: classical HL and nodular lymphocyte predominant HL. Nodular sclerosis, mixed cellularity, lymphocyte depletion, and lymphocyte-rich HL are subgroups of class …
DIAGNOSIS: Hodgkin lymphoma is composed of two distinct disease entities: classical HL and nodular lymphocyte pr …
Management of limited-stage Hodgkin lymphoma.
Al-Juhaishi T, Ahmed S. Al-Juhaishi T, et al. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):500-509. doi: 10.1182/hematology.2023000511. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066938 Free article.
Hodgkin lymphoma (HL) is a rare type of B-cell malignancy with bimodal age distribution targeting young adults and elderly. ...Balancing efficacy and the risk of late effects in Hodgkin lymphoma is essential, including early detection of potenti …
Hodgkin lymphoma (HL) is a rare type of B-cell malignancy with bimodal age distribution targeting young adults and elde …
The treatment of older Hodgkin lymphoma patients.
Böll B, Görgen H. Böll B, et al. Br J Haematol. 2019 Jan;184(1):82-92. doi: 10.1111/bjh.15652. Epub 2018 Nov 8. Br J Haematol. 2019. PMID: 30407626 Free article. Review.
The outcome of patients with Hodgkin lymphoma (HL) has dramatically improved over the past decades and continues to improve with the development of novel targeted therapies, such as the immunoconjugate brentuximab vedotin and the checkpoint inhibitors nivolum …
The outcome of patients with Hodgkin lymphoma (HL) has dramatically improved over the past decades and continues to improve wi …
Treatment of classical Hodgkin's lymphoma in children and adolescents.
Gómez-Almaguer D, González-Llano O, Jiménez-Antolinez V, Gómez-De León A. Gómez-Almaguer D, et al. Expert Opin Pharmacother. 2019 Jul;20(10):1227-1234. doi: 10.1080/14656566.2019.1606212. Epub 2019 Apr 25. Expert Opin Pharmacother. 2019. PMID: 31021660 Review.
INTRODUCTION: The treatment of classical Hodgkin lymphoma (cHL) in children is a story of success. Nowadays, more than 90% of patients are cured and overall survival is nearly 100% at 5 years. Efforts have been made to avoid related effects of therapies; ther …
INTRODUCTION: The treatment of classical Hodgkin lymphoma (cHL) in children is a story of success. Nowadays, more than 90% of …
Diagnosis and management of Hodgkin lymphoma in children, adolescents, and young adults.
Belsky JA, Hochberg J, Giulino-Roth L. Belsky JA, et al. Best Pract Res Clin Haematol. 2023 Mar;36(1):101445. doi: 10.1016/j.beha.2023.101445. Epub 2023 Feb 3. Best Pract Res Clin Haematol. 2023. PMID: 36907636 Review.
Advances in the management of Hodgkin lymphoma in children, adolescents and young adult have resulted in survival outcomes exceeding 90%. ...This has been accomplished through response-adapted treatment approaches and the incorporation of novel agents, many o …
Advances in the management of Hodgkin lymphoma in children, adolescents and young adult have resulted in survival outco …
Lymphoma as an Exclusion Criteria for CVID Diagnosis Revisited.
Allain V, Grandin V, Meignin V, Bertinchamp R, Boutboul D, Fieschi C, Galicier L, Gérard L, Malphettes M, Bustamante J, Fusaro M, Lambert N, Rosain J, Lenoir C, Kracker S, Rieux-Laucat F, Latour S, de Villartay JP, Picard C, Oksenhendler E. Allain V, et al. J Clin Immunol. 2023 Jan;43(1):181-191. doi: 10.1007/s10875-022-01368-5. Epub 2022 Sep 26. J Clin Immunol. 2023. PMID: 36155879
RESULTS: A total of forty-seven patients had developed 54 distinct lymphomas: non-Hodgkin B cell lymphoma (67%), Hodgkin lymphoma (26%), and T cell lymphoma (7%). ...In this group of patients, Hodgkin lymphoma was overrepresented c …
RESULTS: A total of forty-seven patients had developed 54 distinct lymphomas: non-Hodgkin B cell lymphoma (67%), Hodgkin …
ACR Appropriateness Criteria Hodgkin Lymphoma-Favorable Prognosis Stage I and II.
Dhakal S, Advani R, Ballas LK, Dabaja BS, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS; Expert Panel on Radiation Oncology–Lymphoma. Dhakal S, et al. Am J Clin Oncol. 2016 Dec;39(6):535-544. doi: 10.1097/COC.0000000000000331. Am J Clin Oncol. 2016. PMID: 27643717 Free PMC article. Review.
This topic addresses the treatment of newly diagnosed patients with favorable prognosis stage I and II Hodgkin lymphoma. In most cases, combined modality therapy (chemotherapy followed by involved site radiation therapy) constitutes the current standar …
This topic addresses the treatment of newly diagnosed patients with favorable prognosis stage I and II Hodgkin lymphoma. In mo …
Multidisciplinary Management of Adolescent and Young Adult Patients with Hodgkin Lymphoma.
Galloway E, Griffith M, Rosenthal A. Galloway E, et al. Curr Treat Options Oncol. 2021 Jun 7;22(7):64. doi: 10.1007/s11864-021-00861-0. Curr Treat Options Oncol. 2021. PMID: 34097142 Review.
Successful management of adolescent and young adult patients with Hodgkin lymphoma (HL) requires a multidisciplinary approach to care with special attention paid to the unique medical, logistical, and psychosocial challenges faced by this group. ...Cur …
Successful management of adolescent and young adult patients with Hodgkin lymphoma (HL) requires a multidisciplinary ap …
1,561 results